ASX

Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary

Retrieved on: 
Tuesday, July 16, 2024

MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and serious disease, is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary.

Key Points: 
  • MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and serious disease, is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary.
  • More recently, in roles as an executive, interim or non-executive director he has been supporting emerging, technology-driven businesses scale, grow, transform and raise capital.
  • CEO, Simon Morriss, commented, “We are pleased to have Mark join our team.
  • His extensive experience in leadership roles across multiple industries will add enormous value to our team”.

Recce Pharmaceuticals Receives $2 Million Grant from U.S. Department of Defense for RECCE® 327 Gel

Retrieved on: 
Tuesday, July 16, 2024

SYDNEY, July 16, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), the Company developing a new class of synthetic anti-infectives, today announced it has been awarded $2 million in grant funding from the U.S. Department of Defense in recognition of RECCE® 327 Gel (R327G) as a topical treatment for burn wound infections.

Key Points: 
  • SYDNEY, July 16, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), the Company developing a new class of synthetic anti-infectives, today announced it has been awarded $2 million in grant funding from the U.S. Department of Defense in recognition of RECCE® 327 Gel (R327G) as a topical treatment for burn wound infections.
  • “We are honored by the U.S. Department of Defense’s decision to award grant funding for R327G, as it underscores our commitment to advancing medical solutions critical to military personnel,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • “This recognition is a testament to our technology’s unique profile and high-quality R&D.
  • This strategic financial move underscores Recce's commitment to advancing innovative therapies and strengthening its market presence.

Marex Opens New Zealand Office

Retrieved on: 
Tuesday, July 16, 2024

AUCKLAND, New Zealand, July 16, 2024 (GLOBE NEWSWIRE) -- Marex Group Plc (NASDAQ: MRX), the diversified global financial services platform, has opened a new office in Auckland, New Zealand, as it expands its operations in Asia Pacific and extends its global environmental offering, aligned with its strategy to diversify its business and increase earnings resilience.

Key Points: 
  • AUCKLAND, New Zealand, July 16, 2024 (GLOBE NEWSWIRE) -- Marex Group Plc (NASDAQ: MRX), the diversified global financial services platform, has opened a new office in Auckland, New Zealand, as it expands its operations in Asia Pacific and extends its global environmental offering, aligned with its strategy to diversify its business and increase earnings resilience.
  • Marex’s New Zealand office will provide expertise in the financial and commodity markets with an experienced team, led by Nigel Brunel, who brings to Marex almost two decades of experience in global commodities.
  • This new office marks another step in Marex’s strategy to expand its geographic reach across Asia Pacific, adding more clients and connecting those clients to more markets.
  • Marex will launch a new customer-focused carbon trading platform, Neon Carbon, for domestic compliance credits.

ACC Moving to Cloud on the FINEOS Platform

Retrieved on: 
Monday, July 15, 2024

FINEOS Corporation ( ASX:FCL ), the global leader of group and individual core software for life, accident and health insurance, announced today that the Accident Compensation Corporation ( ACC ) will upgrade its on-premise implementation of FINEOS Claims and Payments to the FINEOS Platform .

Key Points: 
  • FINEOS Corporation ( ASX:FCL ), the global leader of group and individual core software for life, accident and health insurance, announced today that the Accident Compensation Corporation ( ACC ) will upgrade its on-premise implementation of FINEOS Claims and Payments to the FINEOS Platform .
  • The Accident Compensation Corporation (ACC) is the crown entity set up under the Accident Compensation Act 2001, (the AC Act) to deliver New Zealand’s accident insurance scheme.
  • "Moving the FINEOS Claims and Payment solution to the cloud will provide new capabilities to support the ACC scheme.
  • We look forward to continuing to support ACC in their mission to provide exceptional claims management services to the people of New Zealand."

Immuron announces record Travelan® sales globally, Australia and USA

Retrieved on: 
Monday, July 15, 2024

MELBOURNE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce record sales (unaudited) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and the toxins they produce in the gastrointestinal (GI) tract.

Key Points: 
  • Flavio Palumbo, Chief Commercial Officer, said, “We continue to be excited by the strong sales results on Travelan®.
  • Immuron’s investment to drive awareness of the Travelan® brand has seen continued strong sales results in Australia.
  • We were incredibly pleased to achieve record U.S. sales in FY24.
  • Sales of Travelan® increased 209% to AUD $1.0 million for the June 2024 Quarter compared to AUD $0.3 million for the June 2023 Quarter (excludes sales of Protectyn®).

American Rare Earths 2024 Drilling commences in Cowboy State Mine Area

Retrieved on: 
Monday, July 15, 2024

DENVER, July 15, 2024 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce commencement of the drilling campaign at the Cowboy State Mine (“CSM”) area. This first stage of in-fill drilling will allow ARR to upgrade resource estimates at CSM while providing key data for pit design, environmental baseline studies and additional ore material for metallurgical test work. The 23-hole program contains 11 core holes and 12 reverse circulation (“RC”) holes with a planned meterage of approximately 2,670 meters.

Key Points: 
  • ARR 2024 drilling campaign commences at Cowboy State Mine Area for a total of 2,670 m including:
    Drill campaign in the Cowboy State Mine area will upgrade resources, provide additional material for metallurgical test work and data to advance mine planning work towards prefeasibility analysis.
  • DENVER, July 15, 2024 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce commencement of the drilling campaign at the Cowboy State Mine (“CSM”) area.
  • Donald Swartz, CEO of American Rare Earths, commented:
    "We are excited to commence our 2024 drilling campaign at the Cowboy State Mine area.
  • Richard Hudson, Chairman of American Rare Earths, commented:
    "This drilling program marks another significant step forward in advancing the project towards prefeasibility analysis.

Hot Chili Appoints Chief Financial Officer

Retrieved on: 
Monday, July 15, 2024

PERTH, Australia, July 15, 2024 /PRNewswire/ - Hot Chili Limited (ASX: HCH) (TSXV: HCH) (OTCQX: HHLKF) ("Hot Chili" or "Company") is pleased to announce the appointment of Ryan Finkelstein as Chief Financial Officer (CFO) effective 15 July 2024.

Key Points: 
  • PERTH, Australia, July 15, 2024 /PRNewswire/ - Hot Chili Limited (ASX: HCH) (TSXV: HCH) (OTCQX: HHLKF) ("Hot Chili" or "Company") is pleased to announce the appointment of Ryan Finkelstein as Chief Financial Officer (CFO) effective 15 July 2024.
  • Hot Chili's Managing Director and CEO, Christian Easterday Comments
    "Ryan is a well accomplished finance executive who is energetic and passionate and is a sound financial operator who thinks strategically.
  • I look forward to working with Ryan and welcoming him as key member of the leadership team.
  • Deborah remains with Hot Chili in her role as Financial Controller.

Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer

Retrieved on: 
Monday, July 15, 2024

MELBOURNE, Australia, and PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, Opthea, the Company), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announces the successful completion of the fully underwritten retail component (Retail Entitlement Offer) of its 1 for 1.22 pro-rata accelerated non-renounceable entitlement offer (Entitlement Offer) of new fully paid ordinary shares in Opthea (New Shares) which opened on Wednesday, 19 June 2024.

Key Points: 
  • New Shares under the Retail Entitlement Offer and New Options under the Placement and Entitlement Offer expected to commence normal trading on Thursday, 18 July 2024
    MELBOURNE, Australia, and PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, Opthea, the Company), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announces the successful completion of the fully underwritten retail component (Retail Entitlement Offer) of its 1 for 1.22 pro-rata accelerated non-renounceable entitlement offer (Entitlement Offer) of new fully paid ordinary shares in Opthea (New Shares) which opened on Wednesday, 19 June 2024.
  • The Retail Entitlement Offer closed at 5:00pm Melbourne time on Wednesday, 10 July 2024, raising approximately A$55.9 million (US$36.9 million1).
  • Shortfall New Shares under the Retail Entitlement Offer will be subscribed for by the underwriter to the Retail Entitlement Offer, MST Financial Services Limited, or sub-underwriters, in accordance with the arrangements described in the Prospectus lodged with ASX on Wednesday, 12 June 2024.
  • Allotment and issue of New Shares and New Options under the Retail Entitlement Offer, and New Options issued under the Institutional Entitlement Offer and Placement

NOVONIX to Host Second Quarter 2024 Operations Update

Retrieved on: 
Sunday, July 14, 2024

BRISBANE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, today announced that it released its second quarter 2024 Quarterly Activities Report today, Monday, July 15, 2024.

Key Points: 
  • BRISBANE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, today announced that it released its second quarter 2024 Quarterly Activities Report today, Monday, July 15, 2024.
  • Dr. Chris Burns, CEO of NOVONIX, will also provide prepared remarks of the quarterly activities for the quarter ended June 30, 2024.
  • The webcast link and presentation materials are available at 8:30 am AEST or Sunday, July 14, 2024 at 6:30 pm EDT for interested parties in the United States.
  • This announcement has been authorized for release by NOVONIX Chairman, Admiral Robert J. Natter, USN Ret.

Patriot Files Preliminary Base Shelf Prospectus

Retrieved on: 
Friday, July 12, 2024

Patriot President, Managing Director & CEO Ken Brinsden said: "Given Patriot supports both a TSX and ASX listing, the filing of a Base Shelf Prospectus better aligns the share issue process on TSX with ASX outcomes.

Key Points: 
  • Patriot President, Managing Director & CEO Ken Brinsden said: "Given Patriot supports both a TSX and ASX listing, the filing of a Base Shelf Prospectus better aligns the share issue process on TSX with ASX outcomes.
  • Importantly, and generally speaking, securities issued under a shelf prospectus supplement filed under a base shelf prospectus are not subject to a four month mandatory hold period in Canada.
  • The Company has no immediate plans to issue securities under the base shelf prospectus, and may never issue any securities under this prospectus.
  • When made final or effective, the base shelf prospectus will allow the Company to offer and issue common shares, preferred shares, debt securities, warrants, subscription receipts, units or any combination thereof for up to an aggregate offering price of C$250 million during the 25-month period that the base shelf prospectus is effective.